Finished
Assessment of a Robotic Distal Gastrectomy on Non-inferiority of N2 Area Nodal Dissection
NCT02572050 · National Cancer Center, Korea · Updated 20 Oct 2026
- What is being tested
- Distal Gastrectomy with D2 LND
- For
- Gastric Cancer
- Kind of study
- Tests a treatment or device on volunteers. Phase 2.
- Who can join
- Ages 19 years and older. About 87 people. The full rules are on the registry page.
- Where
- South Korea (2 sites)
- When
- Starts or started 17 Aug 2015, ends 31 July 2026. Registered 8 Oct 2015.
- Results
- None posted yet.
In the researchers' words
Designed as a single arm multi-center prospective phase II trial, which evaluates the number of dissected lymph nodes in the N2-area as a surrogate parameter for adequate D2 lymphadenectomy in robotic distal gastrectomy (RDG) for clinical stage II or III gastric cancer.
Sites
- National Cancer Center of KoreaGoyang-si, Gyeonggi-do, South Korea
- Aju University HospitalSuwon, Gyeonggi-do, South Korea